Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies (Q37441525)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies
scientific article

    Statements

    Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies (English)
    David S Hong
    Said M Sebti
    Robert A Newman
    Michelle A Blaskovich
    Robert F Gagel
    Stacy Moulder
    Jennifer J Wheler
    Nizar M Tannir
    Chaan S Ng
    Steven I Sherman
    Adel K El Naggar
    Rabia Khan
    Jon Trent
    John J Wright
    10 November 2009
    7061-7068

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit